These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17696420)

  • 1. Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor.
    Tancredi T; Guerrini R; Marzola E; Trapella C; Calo G; Regoli D; Reinscheid RK; Camarda V; Salvadori S; Temussi PA
    J Med Chem; 2007 Sep; 50(18):4501-8. PubMed ID: 17696420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation.
    Roth AL; Marzola E; Rizzi A; Arduin M; Trapella C; Corti C; Vergura R; Martinelli P; Salvadori S; Regoli D; Corsi M; Cavanni P; Caló G; Guerrini R
    J Biol Chem; 2006 Jul; 281(30):20809-20816. PubMed ID: 16720571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.
    Guerrini R; Salvadori S; Rizzi A; Regoli D; Calo' G
    Med Res Rev; 2010 Sep; 30(5):751-77. PubMed ID: 19824051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.
    Guerrini R; Camarda V; Trapella C; Calò G; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    J Med Chem; 2009 Jan; 52(2):524-9. PubMed ID: 19113861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of human neuropeptide S analogues modified in position 2.
    Camarda V; Trapella C; Calo G; Guerrini R; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    J Med Chem; 2008 Feb; 51(3):655-8. PubMed ID: 18181564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I.
    Bernier V; Stocco R; Bogusky MJ; Joyce JG; Parachoniak C; Grenier K; Arget M; Mathieu MC; O'Neill GP; Slipetz D; Crackower MA; Tan CM; Therien AG
    J Biol Chem; 2006 Aug; 281(34):24704-12. PubMed ID: 16790440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor.
    Darker JG; Porter RA; Eggleston DS; Smart D; Brough SJ; Sabido-David C; Jerman JC
    Bioorg Med Chem Lett; 2001 Mar; 11(5):737-40. PubMed ID: 11266181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1.
    Camarda V; Ruzza C; Rizzi A; Trapella C; Guerrini R; Reinscheid RK; Calo G
    Peptides; 2013 Oct; 48():27-35. PubMed ID: 23911665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR conformational studies of micelle-bound orexin-B: a neuropeptide involved in the sleep/awake cycle and feeding regulation.
    Miskolzie M; Lucyk S; Kotovych G
    J Biomol Struct Dyn; 2003 Dec; 21(3):341-51. PubMed ID: 14616030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat.
    Cifani C; Micioni Di Bonaventura MV; Cannella N; Fedeli A; Guerrini R; Calo G; Ciccocioppo R; Ubaldi M
    Peptides; 2011 Jan; 32(1):44-50. PubMed ID: 20971145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.
    Guerrini R; Camarda V; Trapella C; Caló G; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    J Med Chem; 2009 Jul; 52(13):4068-71. PubMed ID: 19473027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central Neuropeptide S inhibits food intake in mice through activation of Neuropeptide S receptor.
    Peng YL; Han RW; Chang M; Zhang L; Zhang RS; Li W; Han YF; Wang R
    Peptides; 2010 Dec; 31(12):2259-63. PubMed ID: 20800637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
    Camarda V; Rizzi A; Ruzza C; Zucchini S; Marzola G; Marzola E; Guerrini R; Salvadori S; Reinscheid RK; Regoli D; Calò G
    J Pharmacol Exp Ther; 2009 Feb; 328(2):549-55. PubMed ID: 18971372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of human and murine neuropeptide s receptor variants.
    Reinscheid RK; Xu YL; Okamura N; Zeng J; Chung S; Pai R; Wang Z; Civelli O
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1338-45. PubMed ID: 16144971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexin-A is composed of a highly conserved C-terminal and a specific, hydrophilic N-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor.
    Takai T; Takaya T; Nakano M; Akutsu H; Nakagawa A; Aimoto S; Nagai K; Ikegami T
    J Pept Sci; 2006 Jul; 12(7):443-54. PubMed ID: 16429482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies.
    Ruzza C; Rizzi A; Camarda V; Pulga A; Marzola G; Filaferro M; Novi C; Ruggieri V; Marzola E; Vitale G; Salvadori S; Guerrini R; Calo' G
    Peptides; 2012 Apr; 34(2):404-11. PubMed ID: 22342393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity study at positions 3 and 4 of human neuropeptide S.
    Camarda V; Trapella C; Calo' G; Guerrini R; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    Bioorg Med Chem; 2008 Oct; 16(19):8841-5. PubMed ID: 18793857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR conformational analyses on (des-bromo) neuropeptide B [1-23] and neuropeptide W [1-23]: the importance of alpha-helices, a cation-pi interaction and a beta-turn.
    Lucyk S; Miskolzie M; Kotovych G
    J Biomol Struct Dyn; 2005 Aug; 23(1):77-90. PubMed ID: 15918679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor.
    Ruzza C; Asth L; Guerrini R; Trapella C; Gavioli EC
    Neuropharmacology; 2015 Oct; 97():1-6. PubMed ID: 25979487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide S receptor ligands: a patent review (2005-2016).
    Ruzza C; Calò G; Di Maro S; Pacifico S; Trapella C; Salvadori S; Preti D; Guerrini R
    Expert Opin Ther Pat; 2017 Mar; 27(3):347-362. PubMed ID: 27788040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.